1. Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterology. 2019;156(1):254-72.e11. [DOI:10.1053/j.gastro.2018.08.063]

2. Bray F, Balcaen T, Baro E, Gandon A, Ficheur G, Chazard E. Increased incidence of cholecystectomy related to gallbladder disease in France: Analysis of 807,307 cholecystectomy procedures over a period of seven years. J Visc Surg. 2019;156(3):209-15. [DOI:10.1016/j.jviscsurg.2018.12.003]

3. Enochsson L, Sharp N, Gimberg K, Sandblom G. The location of bile duct stones may affect intra- and postoperative cholecystectomy outcome: A population-based registry study. The American Journal of Surgery. 2020;220(4):1038-43. [DOI:10.1016/j.amjsurg.2020.03.016]

4. Halldestam I, Enell EL, Kullman E, Borch K. Development of symptoms and complications in individuals with asymptomatic gallstones. British Journal of Surgery. 2004;91(6):734-8. [DOI:10.1002/bjs.4547]

5. Ansari-Moghaddam A, Khorram A, Miri-Bonjar M, Mohammadi M, Ansari H. The Prevalence and Risk Factors of Gallstone Among Adults in South-East of Iran: A Population-Based Study. Glob J Health Sci. 2015;8(4):60-7. [DOI:10.5539/gjhs.v8n4p60]

6. Di Ciaula A, Wang DQ, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr Opin Gastroenterol. 2018;34(2):71-80. [DOI:10.1097/MOG.0000000000000423]

7. Thamer SJ. Pathogenesis, Diagnosis and Treatment of Gallstone Disease: A Brief Review. Biomedicine and Chemical Sciences. 2022;1(2):70-7. [DOI:10.48112/bcs.v1i2.99]

8. Parra-Landazury Nela M, Cordova-Gallardo J, Méndez-Sánchez N. Obesity and Gallstones. Visceral Medicine. 2021;37(5):394-402. [DOI:10.1159/000515545]

9. Nervi F, Miquel JF, Alvarez M, Ferreccio C, García-Zattera MJ, González R, et al. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population. Journal of Hepatology. 2006;45(2):299-305. [DOI:10.1016/j.jhep.2006.01.026]

10. Ngowi EE, Gao Y, Yang X, Qiao A. Editorial: Advances in novel drugs and targets for hepatic and gastrointestinal diseases. Front Pharmacol. 2024;15:1364290. [DOI:10.3389/fphar.2024.1364290]

11. Calugar L, Grozea I, Butnariu M. Vegetable Oils in Maintaining Health. 2024;2:1-7. [DOI:10.1016/B978-0-12-822189-1.00009-X]

12. Li Z, Mo R-l, Gong J-f, Han L, Wang W-f, Huang D-k, et al. Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation. Phytomedicine. 2024;129:155661. [DOI:10.1016/j.phymed.2024.155661]

13. Saadati S, Salehi-Sahlabadi A, Hosseini-Oskouiee F, Aghamohammadi V, Ramezani M, Askari B, et al. Dietary Total Antioxidant Capacity and Risk of Gall Stone: A Case-Control Study. Int J Prev Med. 2021;12:178. [DOI:10.4103/ijpvm.IJPVM_245_20]

14. Ruano-Ravina A, Pérez-Ríos M, Barros-Dios JM. Population-based versus hospital-based controls: are they comparable? Gac Sanit. 2008;22(6):609-13. [DOI:10.1016/S0213-9111(08)75363-9]

15. Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr. 2012;108(6):1109-17. [DOI:10.1017/S0007114511006313]

16. Lee RD, Nieman DC. Nutritional Assessment: McGraw-Hill Education; 2001.

17. Schwesinger WH, Kurtin WE, Page CP, Stewart RM, Johnson R. Soluble dietary fiber protects against cholesterol gallstone formation. Am J Surg. 1999;177(4):307-10. [DOI:10.1016/S0002-9610(99)00047-1]

18. Jessri M, Rashidkhani B. Dietary patterns and risk of gallbladder disease: a hospital-based case-control study in adult women. J Health Popul Nutr. 2015;33(1):39-49.

19. Sheng B, Zhao Q, Ma M, Zhang J. An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study. Lipids in Health and Disease. 2020;19(1):228. [DOI:10.1186/s12944-020-01402-8]

20. Naseri K, Saadati S, Asadzadeh-Aghdaei H, Hekmatdoost A, Sadeghi A, Sobhani SR, et al. Healthy Dietary Pattern Reduces Risk of Gallstones: Results of a Case-Control Study in Iran. Int J Prev Med. 2022;13:66. [DOI:10.4103/ijpvm.IJPVM_455_19]

21. Mishra SK, Bhunia S, Singh J, Shrivastav B, Tiwari P. Assessment of Dietary Habit Associated with Gallbladder Cancer and Gallbladder Diseases: A Case-control Study. Journal of Cancer Epidemiology and Prevention. 2024;8:17.

22. Koppisetti S, Jenigiri B, Terrón M, Tengattini S, Tamura H, Alvarado L, et al. Reactive Oxygen Species and the Hypomotility of the Gall Bladder as Targets for the Treatment of Gallstones with Melatonin: A Review. Digestive diseases and sciences. 2008;53:2592-603. [DOI:10.1007/s10620-007-0195-5]

23. Bali GPK, Singh B, Ashraf M, Kamalanathan T. Chapter 4 - Factors prevailing for gallstone formation. In: Sharma R, Sharma SR, Prasad R, editors. Gallstone Formation, Diagnosis, Treatment and Prevention: Academic Press; 2024. p. 39-50. [DOI:10.1016/B978-0-443-16098-1.00005-9]

24. E S, Srikanth MS, Shreyas A, Desai S, Mehdi S, Gangadharappa HV, et al. Recent advances, novel targets and treatments for cholelithiasis; a narrative review. Eur J Pharmacol. 2021;908:174376. [DOI:10.1016/j.ejphar.2021.174376]

25. Zhang C, Dai W, Yang S, Wu S, Kong J. Resistance to Cholesterol Gallstone Disease: Hepatic Cholesterol Metabolism. J Clin Endocrinol Metab. 2024;109(4):912-23. [DOI:10.1210/clinem/dgad528]

26. Grigor'eva IN, Romanova TI. Gallstone Disease and Microbiome. Microorganisms. 2020;8(6). [DOI:10.3390/microorganisms8060835]